Haploidentical hematopoietic cell and kidney transplantation for hematological malignancies and end-stage renal failure

At Massachusetts General Hospital, we pioneered simultaneous hematopoietic cell (HCT)/kidney transplantation from HLA-identical related donors for the treatment of hematological malignancies with end-stage renal failure. We have now extended this to HLA-haploidentical donors in a pilot trial. Six re...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood
Main Authors: Chen, Yi-Bin, Elias, Nahel, Heher, Eliot, McCune, Jeannine S., Collier, Kerry, Li, Shuli, Del Rio, Candice, El-Jawahri, Areej, Williams, Winfred, Tolkoff-Rubin, Nina, Fishman, Jay A., McAfee, Steven, Dey, Bimalangshu R., DeFilipp, Zachariah, O’Donnell, Paul V., Cosimi, A. Benedict, Sachs, David, Kawai, Tatsuo, Spitzer, Thomas R.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2019
Assuntos:
Transplantation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6624971/
https://ncbi.nlm.nih.gov/pubmed/31151984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019000775
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares